Skip to main content
. Author manuscript; available in PMC: 2019 Nov 6.
Published in final edited form as: J Thorac Oncol. 2018 Jul 17;13(9):1393–1399. doi: 10.1016/j.jtho.2018.05.002

Table 3.

Incidence of Treatment-Emergent Adverse Events of All Grades with a Frequency of 10% or Higher

Toxicity Frequency, n (%)
Fatigue 18 (40)
Nausea 12 (27)
Pruritus 10 (22)
Cough 10 (22)
Constipation 10 (22)
Dyspnea 9 (20)
Dizziness 9 (20)
Rash 8 (18)
Diarrhea 7 (16)
Increased aspartate transaminase level 6 (13)
Back pain 6 (13)
Headache 6 (13)
Noncardiac chest pain 6 (13)
Neuropathy 5 (11)
Abdominal pain 5 (11)
Generalized weakness 5 (11)
Decreased lymphocyte count 5 (11)

Note: All the toxicities listed were grade 2 or lower.